EPHA2 and neoplasm: Specifically silences the EphA2 gene through RNA interference, inhibiting tumor progression from multiple dimensions including proliferation, apoptosis, metastasis, angiogenesis, and the immune microenvironment, and can enhance the efficacy in combination with chemotherapy, immunotherapy, and other treatments